Publication related to RSI or an RSI staff member
The risk to human islet cell transplant recipients of acquiring variant Creutzfeldt-Jakob disease: a provisional quantitative risk assessment.
Authors
- ElSaadany, Susie, ElSaadany S,
- Tyshenko, Michael G, Tyshenko MG,
- Oraby, Tamer, Oraby T,
- Malcolm, Andrew J, Malcolm AJ,
- Senior, Peter, Senior P,
- Shapiro, A M James, Shapiro AM,
- Catford, Angela, Catford A,
- Salem, Tarek, Salem T,
- Wu, Jun, Wu J,
- Krewski, Daniel, Krewski D,
- Rohwer, Robert G, Rohwer RG,
YEAR OF PUBLICATION: 2011
SOURCE: Transplantation. 2011 Jul 15;92(1):e2-4. doi: 10.1097/TP.0b013e31821eabab.
JOURNAL TITLE ABBREVIATION: Transplantation
JOURNAL TITLE: Transplantation
ISSN: 1534-6080 (Electronic) 0041-1337 (Linking)
VOLUME: 92
ISSUE: 1
PAGES: e2-4
PLACE OF PUBLICATION: United States
LANGUAGE: eng
DATE OF PUBLICATION: 2011 Jul 15
DATE COMPLETED: 20110824
DATE REVISED: 20110621
MESH DATE: 2011/08/25 06:00
EDAT: 2011/06/22 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1097/TP.0b013e31821eabab [doi]
OWNER: NLM
Related RSI Experts
Chief Risk Scientist
Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Senior Health Risk Analyst
Dr. Michael G. Tyshenko is a Senior Health Risk Analyst at Risk Sciences International (RSI), where he has contributed since 2018 to the organization’s most complex and cross-cutting public health risk issues. As RSI’s lead on chemical peer reviews, he...